{"id":37665,"date":"2020-04-17T07:26:14","date_gmt":"2020-04-17T07:26:14","guid":{"rendered":"http:\/\/i-base.info\/htb\/?p=37665"},"modified":"2020-05-15T10:14:25","modified_gmt":"2020-05-15T10:14:25","slug":"covid-19-vaccine-study-opens-for-recruitment-in-uk","status":"publish","type":"post","link":"https:\/\/i-base.info\/htb\/37665","title":{"rendered":"COVID-19 vaccine study opens for recruitment in UK"},"content":{"rendered":"<p class=\"HTBsubhead3authorcredit\"><strong><span lang=\"EN-US\"><img loading=\"lazy\" decoding=\"async\" class=\" alignright\" src=\"https:\/\/i-base.info\/wp-content\/uploads\/2020\/03\/COVID-19-graphic.png\" width=\"231\" height=\"142\" \/>Simon Collins, HIV i-Base<\/span><\/strong><\/p>\n<p class=\"HTBBODYtext\"><strong><span lang=\"EN-US\">Researchers at University of Oxford working on a preventative COVID-19 vaccine have started screening healthy volunteers (aged 18-55). [1, 2]<\/span><\/strong><\/p>\n<p class=\"HTBBODYtext\"><span lang=\"EN-US\">This is for an upcoming ChAdOx1 nCoV-19 vaccine trial in the Thames Valley Region. The vaccine based on an adenovirus vaccine vector and the SARS-CoV-2 spike protein is already in production but will not be available for several weeks.<\/span><\/p>\n<p class=\"HTBBODYtext\"><span lang=\"EN-US\">The study will enrol 510 participants who will receive the vaccine or a placebo.<\/span><\/p>\n<p class=\"HTBreference-noindent\"><span lang=\"EN-US\">References <\/span><\/p>\n<ol>\n<li class=\"HTBreference-noindent\"><span lang=\"EN-US\">Oxford COVID-19 vaccine programme opens for clinical trial recruitment. (27 March 2020).<br \/>\n<\/span><a href=\"http:\/\/www.ox.ac.uk\/news\/2020-03-27-oxford-covid-19-vaccine-programme-opens-clinical-trial-recruitment#\" rel=\"noopener noreferrer\"><span lang=\"EN-US\">http:\/\/www.ox.ac.uk\/news\/2020-03-27-oxford-covid-19-vaccine-programme-opens-clinical-trial-recruitment#<\/span><\/a><\/li>\n<li>Lane R. Sarah Gilbert: carving a path towards a COVID-19 vaccine. The Lancet. doi: 10.1016\/S0140-6736(20)30796-0 (2020).<br \/>\n<a href=\"https:\/\/www.thelancet.com\/journals\/lancet\/article\/PIIS0140-6736(20)30796-0\/fulltext\" rel=\"noopener noreferrer\">https:\/\/www.thelancet.com\/journals\/lancet\/article\/PIIS0140-6736(20)30796-0\/fulltext<\/a><\/li>\n<\/ol>\n","protected":false},"excerpt":{"rendered":"<p>Simon Collins, HIV i-Base Researchers at University of Oxford working on a preventative COVID-19 vaccine have started screening healthy volunteers (aged 18-55). [1, 2] This is for an upcoming ChAdOx1 nCoV-19 vaccine trial in the Thames Valley Region. The vaccine &hellip;<\/p>\n","protected":false},"author":3,"featured_media":0,"comment_status":"open","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[292,289,288,278],"tags":[],"class_list":["post-37665","post","type-post","status-publish","format-standard","hentry","category-covid-19-vaccine","category-covid-19-transmission","category-covid-19-research-studies","category-covid-19"],"_links":{"self":[{"href":"https:\/\/i-base.info\/htb\/wp-json\/wp\/v2\/posts\/37665","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/i-base.info\/htb\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/i-base.info\/htb\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/i-base.info\/htb\/wp-json\/wp\/v2\/users\/3"}],"replies":[{"embeddable":true,"href":"https:\/\/i-base.info\/htb\/wp-json\/wp\/v2\/comments?post=37665"}],"version-history":[{"count":0,"href":"https:\/\/i-base.info\/htb\/wp-json\/wp\/v2\/posts\/37665\/revisions"}],"wp:attachment":[{"href":"https:\/\/i-base.info\/htb\/wp-json\/wp\/v2\/media?parent=37665"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/i-base.info\/htb\/wp-json\/wp\/v2\/categories?post=37665"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/i-base.info\/htb\/wp-json\/wp\/v2\/tags?post=37665"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}